Title: Thrombolytic therapy for acute ischaemic stroke
Abstract: Recombinant tissue plasminogen activator (rt-PA, also known as alteplase; Actilyse®) is the first and only licensed thrombolytic approved for use in acute ischaemic stroke in the UK. This article reviews the evidence for the role of rt-PA in acute stroke management and how it may improve long-term clinical outcome for selected patients as part of a comprehensive stroke service.
Publication Year: 2004
Publication Date: 2004-03-01
Language: en
Type: review
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 3
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot